Laser treatment of facial vascular lesions

Christie Travelute, P. J. Carniol, G. J. Hruza

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

For years, the traditional 577 to 585-nm pulsed dye laser has provided safe and effective treatment for many facial vascular lesions. Currently, interest is focused on how selective epidermal cooling, longer wavelengths, and varied pulse durations may expand the pulsed dye laser's therapeutic range to include treatment-resistant port wine stains, nonablative wrinkle reduction, scar revision, and nonsurgical flap delay. Despite these manipulations, the generation of objectionable purpura remains a concern to patients with limited lesions. To this effect, a long pulsed 532-nm laser has recently become available. This laser is effective for the treatment of facial telangiectasias and does not cause any purpura. It has had minimal complications in two series.

Original languageEnglish (US)
Pages (from-to)193-201
Number of pages9
JournalFacial Plastic Surgery
Volume17
Issue number3
DOIs
StatePublished - Nov 26 2001

Fingerprint

Blood Vessels
Lasers
Dye Lasers
Purpura
Port-Wine Stain
Telangiectasis
Therapeutics
Cicatrix

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Travelute, Christie ; Carniol, P. J. ; Hruza, G. J. / Laser treatment of facial vascular lesions. In: Facial Plastic Surgery. 2001 ; Vol. 17, No. 3. pp. 193-201.
@article{d8a5a70adbb14679af6c4decb502144a,
title = "Laser treatment of facial vascular lesions",
abstract = "For years, the traditional 577 to 585-nm pulsed dye laser has provided safe and effective treatment for many facial vascular lesions. Currently, interest is focused on how selective epidermal cooling, longer wavelengths, and varied pulse durations may expand the pulsed dye laser's therapeutic range to include treatment-resistant port wine stains, nonablative wrinkle reduction, scar revision, and nonsurgical flap delay. Despite these manipulations, the generation of objectionable purpura remains a concern to patients with limited lesions. To this effect, a long pulsed 532-nm laser has recently become available. This laser is effective for the treatment of facial telangiectasias and does not cause any purpura. It has had minimal complications in two series.",
author = "Christie Travelute and Carniol, {P. J.} and Hruza, {G. J.}",
year = "2001",
month = "11",
day = "26",
doi = "10.1055/s-2001-17973",
language = "English (US)",
volume = "17",
pages = "193--201",
journal = "Facial Plastic Surgery",
issn = "0736-6825",
publisher = "Thieme Medical Publishers",
number = "3",

}

Laser treatment of facial vascular lesions. / Travelute, Christie; Carniol, P. J.; Hruza, G. J.

In: Facial Plastic Surgery, Vol. 17, No. 3, 26.11.2001, p. 193-201.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Laser treatment of facial vascular lesions

AU - Travelute, Christie

AU - Carniol, P. J.

AU - Hruza, G. J.

PY - 2001/11/26

Y1 - 2001/11/26

N2 - For years, the traditional 577 to 585-nm pulsed dye laser has provided safe and effective treatment for many facial vascular lesions. Currently, interest is focused on how selective epidermal cooling, longer wavelengths, and varied pulse durations may expand the pulsed dye laser's therapeutic range to include treatment-resistant port wine stains, nonablative wrinkle reduction, scar revision, and nonsurgical flap delay. Despite these manipulations, the generation of objectionable purpura remains a concern to patients with limited lesions. To this effect, a long pulsed 532-nm laser has recently become available. This laser is effective for the treatment of facial telangiectasias and does not cause any purpura. It has had minimal complications in two series.

AB - For years, the traditional 577 to 585-nm pulsed dye laser has provided safe and effective treatment for many facial vascular lesions. Currently, interest is focused on how selective epidermal cooling, longer wavelengths, and varied pulse durations may expand the pulsed dye laser's therapeutic range to include treatment-resistant port wine stains, nonablative wrinkle reduction, scar revision, and nonsurgical flap delay. Despite these manipulations, the generation of objectionable purpura remains a concern to patients with limited lesions. To this effect, a long pulsed 532-nm laser has recently become available. This laser is effective for the treatment of facial telangiectasias and does not cause any purpura. It has had minimal complications in two series.

UR - http://www.scopus.com/inward/record.url?scp=0035153044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035153044&partnerID=8YFLogxK

U2 - 10.1055/s-2001-17973

DO - 10.1055/s-2001-17973

M3 - Review article

C2 - 11673809

AN - SCOPUS:0035153044

VL - 17

SP - 193

EP - 201

JO - Facial Plastic Surgery

JF - Facial Plastic Surgery

SN - 0736-6825

IS - 3

ER -